Morse Asset Management Inc lifted its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 1.7% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 5,975 shares of the pharmacy operator’s stock after purchasing an additional 100 shares during the quarter. Morse Asset Management Inc’s holdings in Walgreens Boots Alliance were worth $468,000 as of its most recent filing with the SEC.

Several other large investors have also recently modified their holdings of WBA. Waldron LP grew its holdings in shares of Walgreens Boots Alliance by 67.7% during the 1st quarter. Waldron LP now owns 4,500 shares of the pharmacy operator’s stock worth $373,000 after purchasing an additional 1,816 shares during the period. Canada Pension Plan Investment Board grew its holdings in shares of Walgreens Boots Alliance by 28.9% during the 1st quarter. Canada Pension Plan Investment Board now owns 1,982,013 shares of the pharmacy operator’s stock worth $164,606,000 after purchasing an additional 444,900 shares during the period. Brookstone Capital Management grew its holdings in shares of Walgreens Boots Alliance by 0.3% during the 1st quarter. Brookstone Capital Management now owns 17,407 shares of the pharmacy operator’s stock worth $1,446,000 after purchasing an additional 56 shares during the period. Arcadia Investment Management Corp MI grew its holdings in shares of Walgreens Boots Alliance by 0.7% during the 1st quarter. Arcadia Investment Management Corp MI now owns 30,475 shares of the pharmacy operator’s stock worth $2,531,000 after purchasing an additional 200 shares during the period. Finally, Advisor Partners LLC grew its holdings in shares of Walgreens Boots Alliance by 7.2% during the 1st quarter. Advisor Partners LLC now owns 16,156 shares of the pharmacy operator’s stock worth $1,342,000 after purchasing an additional 1,092 shares during the period. Institutional investors and hedge funds own 60.16% of the company’s stock.

A number of analysts have recently issued reports on WBA shares. Morgan Stanley reiterated an “overweight” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. Raymond James Financial, Inc. reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a report on Wednesday, September 27th. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday, August 30th. Royal Bank Of Canada began coverage on Walgreens Boots Alliance in a report on Tuesday, September 19th. They issued an “outperform” rating and a $96.00 price target for the company. Finally, Citigroup Inc. restated a “buy” rating on shares of Walgreens Boots Alliance in a report on Monday, July 3rd. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company. Walgreens Boots Alliance presently has an average rating of “Buy” and an average price target of $91.94.

WARNING: This article was originally posted by Watch List News and is the sole property of of Watch List News. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://www.watchlistnews.com/morse-asset-management-inc-raises-stake-in-walgreens-boots-alliance-inc-wba/1609077.html.

Walgreens Boots Alliance, Inc. (NASDAQ WBA) opened at 75.83 on Thursday. Walgreens Boots Alliance, Inc. has a 1-year low of $75.18 and a 1-year high of $89.69. The stock has a market capitalization of $81.15 billion, a PE ratio of 19.15 and a beta of 1.25. The stock’s 50 day moving average price is $80.34 and its 200 day moving average price is $81.26.

Walgreens Boots Alliance announced that its Board of Directors has authorized a stock buyback program on Thursday, June 29th that permits the company to buyback $5.00 billion in outstanding shares. This buyback authorization permits the pharmacy operator to buy up to 5.9% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s management believes its shares are undervalued.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 12th. Shareholders of record on Friday, August 18th were issued a $0.40 dividend. The ex-dividend date of this dividend was Wednesday, August 16th. This represents a $1.60 dividend on an annualized basis and a yield of 2.11%. This is a positive change from Walgreens Boots Alliance’s previous quarterly dividend of $0.38. Walgreens Boots Alliance’s dividend payout ratio (DPR) is 40.30%.

In other news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total transaction of $218,305.44. Following the sale, the director now owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 13.50% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.